Cereno is planning to launch a new Phase 1 clinical trial to evaluate the pharmacological properties of CS014 in healthy ...

Living with PH feels like an endless financial balancing act, leaving columnist Jen Cueva constantly on the verge of going broke.

Scientists have uncovered key genetic drivers behind blood vessel damage in idiopathic PAH, according to a study.

Researchers developed prediction models to identify premature infants with bronchopulmonary dysplasia who are at risk of ...

I recently went to Washington, D.C., as part of the Pulmonary Hypertension Association’s (PHA) Capitol Hill Day to advocate for the pulmonary hypertension (PH) community and help secure co-sponsorship ...

Requiring continuous flow oxygen is a physical and mental burden, writes columnist Anna Jeter, whose needs have increased over time.

Higher blood levels of allergy molecule IgE were associated with worsening right heart function in people with PAH, a study ...

While columnist Jen Cueva loves her Southern comfort foods, eating a heart-healthy diet is crucial with pulmonary hypertension.

People with PAH often have problems in the tiny blood vessels that deliver oxygen and nutrients to heart cells, according to a study.

An AI-powered model may help identify premature infants at risk for PH and BPD using noninvasive eye pictures, a study has ...

United Therapeutics plans to seek FDA approval of ralinepag after a Phase 3 trial met its main goal in pulmonary arterial hypertension.

GSK (formerly called GlaxoSmithKline) has acquired rights to HS235, an experimental treatment for pulmonary hypertension (PH), now in early clinical testing, that the buyer hopes will become a new ...